Identification and validation of functional roles for three MYC-associated genes in hepatocellular carcinoma

Identification and validation of functional roles for three MYC-associated genes in hepatocellular carcinoma

Background: Aberrations in MYC underlie a large proportion of liver hepatocellular carcinoma (LIHC) cases; however, MYC is difficult to target because of its undruggable structure. We aimed to uncover MYC-associated molecular targets to provide new strategies for LIHC treatment. Methods: LIHC transc...

Full description

Bibliographic Details
Main Authors:	Sha Li, Pei Xue, Xun Diao, Qi-Yu Fan, Kun Ye, Xiao-Mei Tang, Jia Liu, Zhong-Yan Huang, Qing-Hai Tang, Cheng-You Jia, Rui Xin, Zhong-Wei Lv, Ji-Bin Liu, Yu-Shui Ma, Da Fu
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	Journal of Advanced Research
Subjects:	LIHC Tumor Treatment Biomarker Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2090123223000231

Similar Items

Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma
by: Zhenshan Zhang, et al.
Published: (2022-12-01)

Identification of Diagnostic Biomarkers and Subtypes of Liver Hepatocellular Carcinoma by Multi-Omics Data Analysis
by: Xiao Ouyang, et al.
Published: (2020-09-01)

A detailed multi-omics analysis of GNB2 gene in human cancers
by: L. Zhang, et al.
Published: (2022-06-01)

Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer
by: Lei Zhao, et al.
Published: (2023-04-01)

Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinoma
by: Qingbin Liu, et al.
Published: (2023-11-01)

CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancer
by: Kai Yang, et al.
Published: (2024-04-01)

Analysis and experimental validation of the innate immune gene PSMD1 in liver hepatocellular carcinoma and pan-cancer
by: Xing Chen, et al.
Published: (2023-11-01)

Prognostic Value of Long Noncoding RNA DLEU2 and Its Relationship with Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma
by: Fu S, et al.
Published: (2021-11-01)

Clinical Diagnostic and Prognostic Potential of NDRG1 and NDRG2 in Hepatocellular Carcinoma Patients
by: Shaohua Xu, et al.
Published: (2022-06-01)

The combined characteristics of cholesterol metabolism and the immune microenvironment may serve as valuable biomarkers for both the prognosis and treatment of hepatocellular carcinoma
by: Weiyu Bai
Published: (2023-12-01)

Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma
by: Xinyao Hu, et al.
Published: (2022-09-01)

Pan-cancer analysis of SYNGR2 with a focus on clinical implications and immune landscape in liver hepatocellular carcinoma
by: Chunxun Liu, et al.
Published: (2023-05-01)

Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma
by: Xinyao Hu, et al.
Published: (2023-01-01)

Gene amplification derived a cancer‐testis long noncoding RNA PCAT6 regulates cell proliferation and migration in hepatocellular carcinoma
by: Shuaizhou Chen, et al.
Published: (2019-06-01)

Construction of HBV gene-related prognostic and diagnostic models for hepatocellular carcinoma
by: Keqiang Ma, et al.
Published: (2023-01-01)

Identification of hub genes associated with hepatitis B virus-related hepatocellular cancer using weighted gene co-expression network analysis and protein-protein interaction network analysis
by: Wenze Wu, et al.
Published: (2023-09-01)

Identification and in vitro and in vivo validation of the key role of GSDME in pyroptosis-related genes signature in hepatocellular carcinoma
by: Xinyi Chen, et al.
Published: (2023-05-01)

Novel significant stage-specific differentially expressed genes in hepatocellular carcinoma
by: Arjun Sarathi, et al.
Published: (2019-07-01)

ncRNAs-mediated high expression of TICRR promotes tumor cell proliferation and migration and is correlated with poor prognosis and tumor immune infiltration of hepatocellular carcinoma
by: Ke-Jie He, et al.
Published: (2022-12-01)

Translocation of Methionine Adenosyl Transferase MAT2A and Its Prognostic Relevance for Liver Hepatocellular Carcinoma
by: Pei-Yi Chu, et al.
Published: (2023-05-01)

Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy
by: Qinjing Yang, et al.
Published: (2023-03-01)

Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index
by: Kun‐Hao Bai, et al.
Published: (2020-06-01)

Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma
by: Wei Wei, et al.
Published: (2022-07-01)

Sparse Independence Component Analysis for Competitive Endogenous RNA Co-Module Identification in Liver Hepatocellular Carcinoma
by: Yuhu Shi, et al.
Published: (2023-01-01)

Comprehensive analysis of PSME3: from pan-cancer analysis to experimental validation
by: Chengyuan Dong, et al.
Published: (2024-01-01)

System analysis based on the lysosome-related genes identifies HPS4 as a novel therapy target for liver hepatocellular carcinoma
by: Ke‐Jie He, et al.
Published: (2023-09-01)

Long Noncoding RNA OIP5-AS1 Promotes the Progression of Liver Hepatocellular Carcinoma via Regulating the hsa-miR-26a-3p/EPHA2 Axis
by: Yu-Shui Ma, et al.
Published: (2020-09-01)

The Prognostic and Therapeutic Role of Histone Acetylation Modification in LIHC Development and Progression
by: Ji Gao, et al.
Published: (2023-09-01)

Integrative and Comprehensive Pan-Cancer Analysis of Lymphocyte-Specific Protein Tyrosine Kinase in Human Tumors
by: Mingwei Han, et al.
Published: (2022-11-01)

Comprehensive analysis of SLC43A2 on the tumor immune microenvironment and prognosis of liver hepatocellular carcinoma
by: Yan Liao, et al.
Published: (2022-09-01)

Pan-cancer and multi-omics analyses revealed the diagnostic and prognostic value of BAZ2A in liver cancer
by: Yan Liu, et al.
Published: (2024-03-01)

ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC
by: Lingyi Zhou, et al.
Published: (2022-05-01)

Prediction of novel miRNA biomarker candidates for diagnostic and prognostic analysis of STAD and LIHC: An integrated in silico approach
by: Kumkum Kar, et al.
Published: (2021-01-01)

Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis
by: Xiudan Han, et al.
Published: (2022-10-01)

Bioinformatics-Driven Identification of p62 as A Crucial Oncogene in Liver Cancer
by: Ling Wang, et al.
Published: (2022-06-01)

Prognostic prediction using a gene signature developed based on exhausted T cells for liver cancer patients
by: Yu Zhou, et al.
Published: (2024-03-01)

Identification of hepatocellular carcinoma-related subtypes and development of a prognostic model: a study based on ferritinophagy-related genes
by: Ganggang Wang, et al.
Published: (2023-08-01)

Construction of a Myc-associated ceRNA network reveals a prognostic signature in hepatocellular carcinoma
by: Dan-Dan Zhang, et al.
Published: (2021-06-01)

Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma
by: Oluwaseun Adebayo Bamodu, et al.
Published: (2020-03-01)

Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection
by: Fei Ji, et al.
Published: (2018-04-01)